Ocular Oncology

PHILADELPHIA — In this Healio Video Perspective from the Wills Eye Conference, Carol L. Shields, MD, discusses updates in uveal melanoma.

WAIKOLOA, Hawaii — The landscape of ocular oncology is “rapidly evolving” in a way similar to medical oncology, a speaker said during a presentation here.

NEW ORLEANS — Older age at presentation may be associated with a significantly decreased risk for germline mutation in children with solitary unilateral retinoblastoma, according to a presenter here.

WAILEA, Hawaii — The notion that all pigmentation in the eye is melanoma is a “rumor,” according to a speaker at Hawaiian Eye 2021.

Patients with iris melanoma treated with plaque radiotherapy were more likely to develop post-management glaucoma than when other conservative treatments were used, according to a speaker.

A phase 1b/2 open-label clinical trial of patients with choroidal melanoma treated with AU-011 showed a statistically significant reduction in tumor growth rate and favorable preliminary vision, according to a speaker.

The first patient has been dosed in a phase 2 clinical trial investigating safety and efficacy of suprachoroidal administration of AU-011 as a potential treatment for primary choroidal melanoma, according to a press release.

An 8-year-old healthy girl presented to the New England Eye Center retina service for evaluation of a retinal lesion in the right eye.